These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29085361)

  • 41. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
    Gilliet M; Conrad C; Geiges M; Cozzio A; Thürlimann W; Burg G; Nestle FO; Dummer R
    Arch Dermatol; 2004 Dec; 140(12):1490-5. PubMed ID: 15611427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
    Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
    Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
    Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
    PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells.
    Hagberg N; Theorell J; Schlums H; Eloranta ML; Bryceson YT; Rönnblom L
    J Immunol; 2013 Sep; 191(6):2989-98. PubMed ID: 23956418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CCK8 negatively regulates the TLR9-induced activation of human peripheral blood pDCs by targeting TRAF6 signaling.
    Jia X; Cong B; Zhang J; Li H; Liu W; Chang H; Dong M; Ma C
    Eur J Immunol; 2014 Feb; 44(2):489-99. PubMed ID: 24301797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
    Salio M; Palmowski MJ; Atzberger A; Hermans IF; Cerundolo V
    J Exp Med; 2004 Feb; 199(4):567-79. PubMed ID: 14970182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis.
    Silva IS; Ferreira BH; Almeida CR
    Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidative modification enhances the immunostimulatory effects of extracellular mitochondrial DNA on plasmacytoid dendritic cells.
    Pazmandi K; Agod Z; Kumar BV; Szabo A; Fekete T; Sogor V; Veres A; Boldogh I; Rajnavolgyi E; Lanyi A; Bacsi A
    Free Radic Biol Med; 2014 Dec; 77():281-90. PubMed ID: 25301097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormonal Modulation of Dendritic Cells Differentiation, Maturation and Function: Implications for the Initiation and Progress of Systemic Autoimmunity.
    Mackern-Oberti JP; Jara EL; Riedel CA; Kalergis AM
    Arch Immunol Ther Exp (Warsz); 2017 Apr; 65(2):123-136. PubMed ID: 27585815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasmacytoid dendritic cells act as the most competent cell type in linking antiviral innate and adaptive immune responses.
    Zhang Z; Wang FS
    Cell Mol Immunol; 2005 Dec; 2(6):411-7. PubMed ID: 16426490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-155 Mediates Augmented CD40 Expression in Bone Marrow Derived Plasmacytoid Dendritic Cells in Symptomatic Lupus-Prone NZB/W F1 Mice.
    Yan S; Yim LY; Tam RC; Chan A; Lu L; Lau CS; Chan VS
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27509492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.
    Schroeder JT; Chichester KL; Bieneman AP
    J Allergy Clin Immunol; 2008 Feb; 121(2):486-91. PubMed ID: 18036648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation.
    Chistiakov DA; Orekhov AN; Sobenin IA; Bobryshev YV
    Front Physiol; 2014; 5():279. PubMed ID: 25120492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal Activity of Plasmacytoid Dendritic Cells and the Impact of Chronic HIV Infection.
    Maldonado S; Fitzgerald-Bocarsly P
    Front Immunol; 2017; 8():1705. PubMed ID: 29255464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor-forming plasmacytoid dendritic cells in acute myelocytic leukemia: a report of three cases and literature review.
    Wang P; Feng Y; Deng X; Liu S; Qiang X; Gou Y; Li J; Yang W; Peng X; Zhang X
    Int J Clin Exp Pathol; 2017; 10(7):7285-7291. PubMed ID: 31966568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmacytoid Dendritic Cells Respond Directly to Apoptotic Cells by Secreting Immune Regulatory IL-10 or IFN-α.
    Simpson J; Miles K; Trüb M; MacMahon R; Gray M
    Front Immunol; 2016; 7():590. PubMed ID: 28018356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of CD123 (+) Plasmacytoid Dendritic Cells in Etiologically Different Variants of Erythema Multiforme: A Monocentric Retrospective Study.
    Zengin HB; Pukhalskaya T; Smoller BR
    Dermatopathology (Basel); 2021 Apr; 8(2):89-96. PubMed ID: 33916862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus.
    Moreno-Angarita A; Aragón CC; Tobón GJ
    J Transl Autoimmun; 2020; 3():100029. PubMed ID: 32743514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasmacytoid dendritic cells in cutaneous sarcoidosis.
    Halawi A; Kurban M; Abbas O
    Sarcoidosis Vasc Diffuse Lung Dis; 2018; 35(1):55-61. PubMed ID: 32476880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity.
    Castelli C; Triebel F; Rivoltini L; Camisaschi C
    Oncoimmunology; 2014 Nov; 3(11):e967146. PubMed ID: 25941596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.